SCHEMBL5670554

SCHEMBL5670554

COc1ccccc1CNC(=O)c1csc(CNC(=O)CC=Cc2ccccc2)n1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
HTT P42858 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 2/20 0.48
PKM P14618 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 3/20 0.46
ALDH1A1 P00352 1/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
HDAC1 Q13547 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5667932 0.80 SLC40A1 (0.46) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL5667924 0.80 SLC40A1 (0.46) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL2208945 0.79 MAPT (0.72) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL2172635 0.78 MAPT (0.64) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5670457 0.77 MAPT (0.64) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4387696 0.76 MAPT (0.61) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4392388 0.76 MAPT (0.61) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4390910 0.75 MAPT (0.61) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5669690 0.74 MAPT (0.65) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4389708 0.73 MAPT (0.60) MAPTCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730128-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-12-13 EP claimed
WO-2005097765-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-10-20 WO claimed